.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,534,554

« Back to Dashboard

Summary for Patent: 5,534,554

Title: Sucrose ester-C20 to C28 alcohol formulations
Abstract:A stable, efficacious therapeutic cream wherein a principal therapeutic compounds are one or more C-20 to C-28 long chain aliphatic alcohols, of which n-docosanol is exemplary, comprising sucrose cocoate, sucrose stearates or sucrose distearate, or mixtures thereof, is disclosed.
Inventor(s): Katz; David H. (La Jolla, CA), Khalil; Mohammed H. (San Diego, CA), Marcelletti; John F. (San Diego, CA), Pope; Laura E. (Carlsbad, CA), Katz; Lee R. (La Jolla, CA)
Assignee: Lidak Pharmaceuticals (La Jolla, CA)
Application Number:08/299,944
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound; Composition;
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 5,534,554

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria383848<disabled in preview>
Austria399004<disabled in preview>
Australia693476<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc